On heels of record-break­ing Q2, Pfiz­er CEO Al­bert Bourla out­lines plans to ‘go very big’ on BD

Pfiz­er CEO Al­bert Bourla un­corked some record-break­ing Q2 num­bers on Thurs­day, in­clud­ing the com­pa­ny’s high­est-ever quar­ter­ly sales thanks to Comir­naty and Paxlovid, all while rais­ing the full-year guid­ance. What’s he go­ing to do with that cash?

“Go very big” on new deals, he said on the com­pa­ny’s Q2 call with in­vestors.

“We’re leav­ing very few stones un­turned when we look at op­por­tu­ni­ties,” chief busi­ness in­no­va­tion of­fi­cer Aamir Ma­lik added. “We’re go­ing to be very open to deal struc­tures, and we’ve said be­fore we’re al­so go­ing to be ag­nos­tic to size.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER